Brad Listermann

Background

About Brad Listermann

Throughout my career, I have operated at the intersection of deep-tech innovation and capital markets. I don’t just build companies; I architect the strategic and financial frameworks that allow complex technologies to reach the global stage.​My primary mission is the advancement of Xycota Biosciences. We are pioneering breakthroughs in brain repair therapeutics, focused on neuro-restoration and synaptogenesis to treat neurodegenerative disorders like Frontotemporal Dementia (FTD) and ALS. By decoupling therapeutic effects from traditional psychedelic pathways, we are building a scalable, science-backed platform for the future of brain health. ​In parallel, I lead PriviNet. We are revolutionizing home safety and the IoT landscape through the PriviCare platform, a privacy-first network designed to provide cutting-edge AI and IoT connectivity without compromising user data.​The engine behind these ventures is Pulse IR (a Strategic Innovations First, Inc. company). Drawing on my experience as a Public Company Executive (CEO/COO), I lead Investor Relations for select firms and my own ventures. This expertise ensures that while we are building world-class technology, we are also maintaining the clear, compliant, and effective messaging required to build shareholder trust and secure multi-million-dollar capital raises.​Core Expertise:​Life Sciences & IoT: Strategic direction for neuro-restoration and privacy-first AI.​Capital Markets: Investor Relations, multi-million dollar fundraising, and regulatory compliance.​Operational Leadership: Navigating public companies through complex financial landscapes and growth cycles.